Campbell Soup (NYSE:CPB) to Issue Quarterly Dividend of $0.35

Share on StockTwits

Campbell Soup (NYSE:CPB) declared a quarterly dividend on Wednesday, March 25th, RTT News reports. Shareholders of record on Thursday, April 9th will be paid a dividend of 0.35 per share on Monday, April 27th. This represents a $1.40 annualized dividend and a yield of 3.21%.

Campbell Soup has a dividend payout ratio of 52.8% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Campbell Soup to earn $2.72 per share next year, which means the company should continue to be able to cover its $1.40 annual dividend with an expected future payout ratio of 51.5%.

Shares of NYSE CPB traded up $2.18 on Thursday, hitting $43.59. The company’s stock had a trading volume of 5,056,416 shares, compared to its average volume of 4,758,527. Campbell Soup has a 12-month low of $35.27 and a 12-month high of $57.54. The company has a market capitalization of $13.13 billion, a price-to-earnings ratio of 9.14, a price-to-earnings-growth ratio of 2.65 and a beta of 0.51. The company has a debt-to-equity ratio of 1.97, a current ratio of 0.61 and a quick ratio of 0.31. The stock has a 50 day moving average of $48.26 and a 200-day moving average of $47.66.

Campbell Soup (NYSE:CPB) last announced its quarterly earnings results on Wednesday, March 4th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.06. The company had revenue of $2.16 billion for the quarter, compared to the consensus estimate of $2.16 billion. Campbell Soup had a net margin of 17.46% and a return on equity of 50.69%. The company’s revenue for the quarter was down .5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.79 earnings per share. Sell-side analysts expect that Campbell Soup will post 2.7 EPS for the current fiscal year.

CPB has been the subject of a number of recent analyst reports. Barclays reaffirmed a “sell” rating and set a $47.00 price target on shares of Campbell Soup in a report on Friday, March 6th. Wells Fargo & Co raised their price target on shares of Campbell Soup from $48.00 to $54.00 and gave the company an “equal weight” rating in a report on Thursday, March 5th. Royal Bank of Canada reaffirmed a “buy” rating and set a $59.00 price target on shares of Campbell Soup in a report on Monday. UBS Group set a $41.00 price target on shares of Campbell Soup in a report on Thursday, December 5th. They noted that the move was a valuation call. Finally, Goldman Sachs Group lowered shares of Campbell Soup from a “neutral” rating to a “sell” rating and set a $47.00 price objective for the company. in a report on Thursday, March 12th. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $48.67.

Campbell Soup Company Profile

Campbell Soup Company, together with its subsidiaries, manufactures and markets branded food and beverage products. It operates through three segments: Americas Simple Meals and Beverages, Global Biscuits and Snacks, and Campbell Fresh. The Americas Simple Meals and Beverages segment engages in the retail and food service of Campbell's condensed and ready-to-serve soups; Swanson broth and stocks; Prego pasta sauces; Pace Mexican sauces; Campbell's gravies, pastas, beans, and dinner sauces; Swanson canned poultry products; Plum food and snack products; V8 juices and beverages; Campbell's tomato juices; and Pacific broth, soups, non-dairy beverages, and other simple meals.

Further Reading: Book Value Of Equity Per Share – BVPS Explained

Dividend History for Campbell Soup (NYSE:CPB)

Receive News & Ratings for Campbell Soup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Campbell Soup and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.